Glenview Capital Management, LLC Amgen Inc Transaction History

Glenview Capital Management, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $29.5 Million - $32.7 Million	-134,645 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $5.72 Million - $6.55 Million	28,775 Added 27.18%	134,645 $30.3 Million
Q3 2021 Nov 15, 2021	BUY	$212.27 - $248.7 $7.12 Million - $8.35 Million	33,557 Added 46.41%	105,870 $22.5 Million
Q2 2021 Aug 16, 2021	BUY	$233.58 - $259.14 $16.9 Million - $18.7 Million	72,313 New	72,313 $17.6 Million
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $31.4 Million - $36.6 Million	-141,474 Closed	0 $0

Q4 2020 Feb 16, 2021	BUY	$216.38 - $257.67 $20.8 Million - $24.8 Million	96,171 Added 212.28%	141,474 $32.5 Million
Q3 2020 Nov 16, 2020	BUY	$234.65 - $260.95 $10.6 Million - $11.8 Million	45,303 New	45,303 $11.5 Million

2,930

401M

6.59M

6.6M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $167B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Glenview Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Glenview Capital Management, LLC with notifications on news.